Applications: Used for the quantitative determination of Canakinumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 64.37 ng/mL
Range: 62.5 - 4,000 ng/mL
Applications: Used for the quantitative determination of Infliximab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 71.38 ng/mL
Range: 93.75 - 3,000 ng/mL
Applications: Used for the quantitative determination of Golimumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 99.16 ng/mL
Range: 125 - 4,000 ng/mL
Applications: Used for the quantitative determination of Certolizumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 329.66 ng/mL
Range: 468.75 - 30,000 ng/mL
Applications: Used for the quantitative determination of Adalimumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 102.26 ng/mL
Range: 62.5 - 4,000 ng/mL
Applications: Used for the quantitative determination of Tanezumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 128.01 ng/mL
Range: 156.25 - 10,000 ng/mL
Applications: Used for the quantitative determination of Serclutamab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 79.88 ng/mL
Range: 156.25 - 10,000 ng/mL
Applications: Used for the quantitative determination of Panitumumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 36.56 ng/mL
Range: 46.88 - 3,000 ng/mL
Applications: Used for the quantitative determination of Necitumumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 6.05 ng/mL
Range: 9.38 - 600 ng/mL
